Results 181 to 190 of about 952 (211)

Dipeptidyl Peptidase-4 Inhibitors

2014
Ranjit Unnikrishnan, Viswanathan Mohan, Gaurav Beswal   +2 more
openaire   +1 more source

Inhibitors of Dipeptidyl Peptidase 4

2005
Stephen L. Gwaltney, Jeffrey A. Stafford
openaire   +1 more source

Association between Add-On Dipeptidyl Peptidase-4 Inhibitor Therapy and Diabetic Retinopathy Progression

Journal of Clinical Medicine, 2021
Eugene YÜ-CHÜAN Kang, Chi Chin Sun, Chi-Chun Lai   +2 more
exaly  

Dipeptidyl Peptidase-4 Inhibitor-Related Bullous Pemphigoid: Clinical, Laboratory, and Histological Features, and Possible Pathogenesis

International Journal of Molecular Sciences, 2022
Chih-Tsung Hung, Wei-Ming Wang, Yung-Lung Chang   +2 more
exaly  

Dipeptidyl Peptidase-4 (DPP4) Inhibitors

2022
Ngoc-Yen T. Pham, Christos Argyropoulos, Nhan Dinh   +2 more
openaire   +1 more source

The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Ameliorates Endothelial Inflammation and Microvascular Thrombosis in a Sepsis Mouse Model

International Journal of Molecular Sciences, 2022
Chung-Te Liu, Zhen Bouman Chen, Shen-Chih Wang   +2 more
exaly  

Clinical, Laboratory and Histological Features of Dipeptidyl Peptidase-4 Inhibitor Related Noninflammatory Bullous Pemphigoid

Journal of Clinical Medicine, 2021
Zsuzsanna Lengyel, Timea BERKİ, Peter Olah   +2 more
exaly  

Dipeptidyl peptidase 4 inhibitors

Reactions Weekly
openaire   +2 more sources

Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects

Clinical Therapeutics, 2008
Aziz Karim
exaly  

Dipeptidyl peptidase‐4 inhibitors and cardiovascular safety

Medical Journal of Australia, 2014
openaire   +2 more sources